Estimates Revisions Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
18:03:51 12/10/2026 BST
|
After hours 18:35:53 | |||
| 299.74 USD | -0.74% |
|
300.20 | +0.15% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Charles River Laboratories International, Inc.(CRL)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Charles River Laboratories International, Inc.(CRL)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Charles River Laboratories International, Inc.(CRL)
EBIT
Dividend / Share (DPS)
Data source:
Charles River Laboratories International, Inc.(CRL)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
